http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1826568-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af92759c928daeb7f0daabbb0499f059
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9121
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cec336daa0c3c95fa0f3b79d672e059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0824bcea4bf8a08bb50a4c2a2700896c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95de6147a203299b00edaa387b69f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9836c1c622d4411eeea0269ab1f4123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0856632e88549818f5d2beb0d0330540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791227fca87f7eb0ace98e48641099ef
publicationDate 2007-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1826568-A1
titleOfInvention Method for judging feature of malignant tumor
abstract A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200062460-A
priorityDate 2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1686377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005020794-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1600513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1764615-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1750131-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87402224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87402225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226456842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228635978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136039228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243206246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226456843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440317

Total number of triples: 46.